Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU ‘Newmood’ research investigating genetic links to treat depression with new drugs

29.06.2004


120 million people worldwide suffer from depression. An EU-funded research project launched recently will help to uncover the genetic factors linked to depression to develop new drug treatments. The Integrated Project, named NEWMOOD, has received €7.2 million in funding from the EU’s Sixth Research Framework Programme (FP6) and aims to identify genes involved in triggering depression. This will help researchers to develop new drugs over the next five years to treat it and improve understanding of its causes. The drugs are set to revolutionise antidepressant drugs, which have not changed much over the past 30 years. The project, co-ordinated by the University of Manchester (United Kingdom) involves partners from 13 laboratories in 10 European countries including Estonia, France, Germany, Hungary, Italy, the Netherlands, Poland, Slovenia and Spain.

“Depression is a widespread issue and represents a serious health problem in Europe. Everybody can feel sad. But depression is a severe and long-term problem where people feel hopeless and their professional and private life is hampered,” says European Research Commissioner Philippe Busquin. “Traditional drugs mainly target brain chemicals, and are only partially effective. By looking into the genetics of depression EU researchers can go to the very roots of the illness, and help prevent and cure it in innovative ways. European scientists working together can make a difference and achieve a quantum leap in the fight against depression”.

Feeling blue



Depression, which is marked by symptoms of reduced interest and pleasure, weight and appetite changes, agitation and fatigue, is believed to be caused by genetic and environmental factors. Chronic stress, such as long term illness or bereavement, can trigger depression in those genetically predisposed to the condition. Counselling is often used alongside drug treatment, but the NEWMOOD research hopes to find more effective drug treatments by identifying genes affecting depression in mice and rats, and later in humans.

New drugs to take effect sooner

Currently, most antidepressants work by boosting levels of serotonin in the brain, a chemical that allows nerve cells in the brain to communicate with one another. However, such treatments can take weeks to have an effect and only work in around 50% of patients. It is hoped the new drugs will be more effective and quicker to take effect.

Targeting and understanding depression

This gene research will help to provide new targets for the drugs and improve understanding of the key causes of depression. Researchers will develop a microchip carrying 800 genes to test which ones are active in healthy and depressed animals and humans. They will test the effects of these depression-related genes by altering their activity in genetically modified mice. Animal depression can be observed in mice by lower than usual interest in sweetened water and a tendency not to struggle as much when suspended from their tails.

Fabio Fabbi | EU Commission
Further information:
http://europa.eu.int

More articles from Health and Medicine:

nachricht Indications of Psychosis Appear in Cortical Folding
26.04.2018 | Universität Basel

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>